Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Richard Michael Krause (January 4, 1925 – January 6, 2015) was an American physician, microbiologist, and immunologist. He was the director of the National Institute of Allergy and Infectious Diseases from 1975 to 1984.

  2. Richard M. Krause (* 4. Januar 1925 in Marietta (Ohio); † 6. Januar 2015) war ein US-amerikanischer Immunologe und Mikrobiologe. Krause studierte am Marietta College (Bachelor-Abschluss 1947) und studierte Medizin an der Case Western Reserve University School of Medicine (M. D.-Abschluss 1952).

  3. 25. Feb. 2015 · Richard M. Krause, M.D. Jan. 4. 1925–Jan. 6. 2015. Richard Michael Krause, M.D. medical microbiologist, immunologist, and later science administrator, was born in Marietta, Ohio, USA, where his father was professor of chemistry at Marietta College, and where Krause received his BA in 1947. He went on to study medicine at Case ...

    • Klaus Eichmann
    • eichmann@immunbio.mpg.de
    • 2015
  4. Richard M. Krause stands at the Nashville, Tennessee, gravesite of his hero Oswald T. Avery (1877–1955), the Rockefeller scientist who developed bacterial disease immunotherapy and studied the mysterious phenomenon of pneumococcal transformation. The transforming factor turned out to be DNA.

  5. by WYNNE PARRY. Richard M. Krause, a former Rockefeller University faculty member who later became director of the U.S. National Institute of Allergy and Infectious Disease and presciently warned against complacency toward infectious disease, has died at the age of 90.

  6. Richard M. Krause stands at the Nash-ville,Tennessee,gravesiteofhisheroOswaldT.Avery(1877– 1955), the Rockefeller scientist who developed bacterial disease immunotherapy and studied the mysterious phe-nomenon of pneumococcal transformation.

  7. Appointed the director of NIAID in 1975, Dr. Krause was among the first to perceive "the return of the microbes." He guided the Institute through a period of growth to cope with the re-emergence of microbial diseases as health threats and to stimulate research on the complexity of the immune system.